
Ardigen S.A.
Research and experimental development in natural sciences and engineering
Overview
Ardigen is an AI-powered CRO focused on drug discovery and precision medicine. It develops custom AI algorithms and models, including LLM-based drug discovery and foundational models for biology. The company serves biotech and pharmaceutical clients and has completed more than 520 projects for over 100 customers.
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $252,637 |
Filing timeliness
1 of 6 financial statements was filed late (for 2022, 5 days late). All were audited by a statutory auditor.
- 202501/07/2026
- 202410/07/2025
- 202326/06/2024
- 202220/07/2023
- 202113/07/2022
- 202027/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Trademarks
The company holds 2 active trademarks registered with the Polish Patent Office. The first mark was filed in 2018.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| ARDIGEN (word) | Z.592531 | 9, 42, 45 | Protected | Oct 21, 2035 | |
| CODE AGAINST CANCER | Z.482181 | 5, 9, 10, 42, 44 | Protected | Feb 8, 2028 |
| Mark | Protected until | |
|---|---|---|
| ARDIGEN (word) | Oct 21, 2035 | |
| CODE AGAINST CANCER | Feb 8, 2028 |
Authorized Representatives
Manner of representation
The company is represented by two members of the management board acting jointly, or one member of the management board together with a commercial proxy.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2015-11-17.
93 1240 6292 1111 0011 0033 3751
02 1240 2294 1111 0010 9593 6674
71 1240 4432 1111 0010 6525 2920
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 110.5KPLN 110,497 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Dec 4, 2015 | Commercial Companies Code notice |
Public aid
15 public aid cases recorded, with a total value of $7,743,871.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Apr 3, 2024 | Aid for research and development projects: industrial research | $229.6K$229,557 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Sep 28, 2021 | Aid for research and development projects: industrial research | $1.4M$1,391,810 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Sep 28, 2021 | Aid for research and development projects: experimental development | $167.2K$167,200 | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
4 projects co-financed from European Funds recorded, with total EU co-financing of $6,626,620.
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-07-01 | Development of the Microbiome Biomarker Discovery Platform technology, enabling the discovery, using artificial intelligence methods, of candidates for microbiome-derived predictive biomarkers to predict the effectiveness of cancer therapies, in particular ICT (a-PD-1, CTLA-4) and chemotherapy. | $1.6M$1,559,010 | Operational Programme Smart Growth | |
| 2020-08-01 | Development of innovative, artificial intelligence-based TCRact technology to launch a new service for the in silico design of T-cell receptors (TCRs) for use in cancer immunotherapies. | $3M$3,000,641 | Operational Programme Smart Growth | |
| 2017-12-01 | Development of the A.I.mmune technology for creating a bioinformatics component of diagnostic tests used in cancer immunotherapy. | $855.7K$855,708 | Regional Operational Programme for the Małopolskie Voivodeship for 2014-2020 |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Sieć Badawcza Łukasiewicz - Port Polski Ośrodek Rozwoju Technologii Research institute | $24,232,583.73 | port.lukasiewicz.gov.pl | ||
| Tenarai Technologies sp. z o.o. | $14,550,603.63 | tenarai.com | ||
| DS Stream sp. z o.o. | $12,952,386.01 | dsstream.com | ||
| Siili Solutions sp. z o.o. | $9,340,964.74 | siili.com | ||
| Dataserve S.A. | $8,957,118.80 | dataserve.eu | ||
| Lingaro Ecommerce sp. z o.o. | $6,037,616.05 | lingarogroup.com | ||
| Addepto sp. z o.o. | $5,333,694.00 | addepto.com | ||
| 3soft S.A. | $4,495,705.51 | 3soft.pl | ||
| Algomine Group sp. z o.o. | $3,923,326.94 | algomine.pl | ||
| Proacta S.A. | $3,747,821.54 | proacta.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-08-02 | Address change (Ul. Podole 76, 30-394, Kraków → Ul. Leona Henryka Sternbacha 1, 30-394, Kraków) | |
| 2020-09-01 | Share capital increase (277,066.00 PLN → 283,132.00 PLN) | |
| 2020-03-04 | Share capital increase (268,232.00 PLN → 277,066.00 PLN) | |
| 2019-04-24 | Address change (Ul. Prof. Michała Bobrzyńskiego 14, 30-348, Kraków → Ul. Podole 76, 30-394, Kraków) | |
| 2019-01-25 | Share capital increase (254,832.00 PLN → 268,232.00 PLN) |
FAQ
Last updated: 2026-10-03